4.0
May 29, 2025
Current employee, more than 1 year
Berhampore
Recommend
CEO approval
Business Outlook
Pros
Stability Legacy Brands Work culture Market Acceptance
Cons
Slow growth Policy restriction Lack of investment Sale pressure Less molecules in pipeline for GEN MED